CRMD: CorMedix Inc. - Summary | Jitta

CorMedix Inc.

NASDAQ:CRMD

Price
$7.59
Loss Chance
48.4%
2.75JITTA SCORE
76.45%Under Jitta Line
Jitta Ranking
67 / 719
772 / 4,228
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (36)
Recent Business Performance (76)
Financial Strength (67)
Return to Shareholders (22)
Competitive Advantage (41)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
2.75
76.45%
3.14
94.26%
3.07
427.75%
Pharmaceuticals
4.91
50.34%
5.04
76.39%
5.32
90.39%
COMPANY DESCRIPTION
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.